BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 14969044)

  • 1. A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritis.
    Sokka T; Pincus T
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S5-14. PubMed ID: 14969044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Databases of patients with early rheumatoid arthritis in the USA.
    Sokka T; Willoughby J; Yazici Y; Pincus T
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S146-53. PubMed ID: 14969067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The origins, results and consequences of the 1995 Arthritis Research Campaign Low-Dose Glucocorticoid Study.
    Kirwan J
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S52-8. PubMed ID: 22018184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug management of early rheumatoid arthritis - 2008.
    Sokka T; Mäkinen H
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of rheumatoid arthritis: the historical context.
    Moreland LW; Russell AS; Paulus HE
    J Rheumatol; 2001 Jun; 28(6):1431-52. PubMed ID: 11409142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uniform databases in early arthritis: specific measures to complement classification criteria and indices of clinical change.
    Pincus T; Sokka T
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S79-88. PubMed ID: 14969056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials to establish methotrexate as a therapy for rheumatoid arthritis.
    Coury FF; Weinblatt ME
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S9-12. PubMed ID: 21044426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in use of methotrexate since the 1980s.
    Sokka T
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S13-20. PubMed ID: 21044427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Historical overview of the treatment of rheumatoid arthritis with an emphasis on methotrexate.
    Kremer JM
    J Rheumatol Suppl; 1996 Mar; 44():34-7. PubMed ID: 8833049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
    Gerber LH; Furst G; Yarboro C; el-Gabalawy H
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis.
    Sokka T; Pincus T
    Arthritis Rheum; 2003 Feb; 48(2):313-8. PubMed ID: 12571838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy in early rheumatoid arthritis.
    Gossec L; Dougados M
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S174-8. PubMed ID: 14969072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study.
    van Aken J; van Dongen H; le Cessie S; Allaart CF; Breedveld FC; Huizinga TW
    Ann Rheum Dis; 2006 Jan; 65(1):20-5. PubMed ID: 15901632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs].
    Pasero G; Marson P
    Reumatismo; 2011; 63(2):111-23. PubMed ID: 21776448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs.
    Abu-Shakra M; Toker R; Flusser D; Flusser G; Friger M; Sukenik S; Buskila D
    Arthritis Rheum; 1998 Jul; 41(7):1190-5. PubMed ID: 9663474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern treatment strategies in rheumatoid arthritis.
    Hetland ML
    Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.